Plasma levels of progranulin and interleukin-6 in frontotemporal lobar degeneration

We have measured plasma progranulin and interleukin-6 in 230 patients with frontotemporal lobar degeneration (FTLD), 104 patients with Alzheimer's disease, and 161 control subjects. We have replicated previous findings of decreased levels of progranulin protein in FTLD because of mutations in G...

Descripción completa

Detalles Bibliográficos
Autores principales: Gibbons, Linda, Rollinson, Sara, Thompson, Jennifer C., Robinson, Andrew, Davidson, Yvonne S., Richardson, Anna, Neary, David, Pickering-Brown, Stuart M., Snowden, Julie S., Mann, David M.A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Genetic Report Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4504979/
https://www.ncbi.nlm.nih.gov/pubmed/25435337
http://dx.doi.org/10.1016/j.neurobiolaging.2014.10.023
Descripción
Sumario:We have measured plasma progranulin and interleukin-6 in 230 patients with frontotemporal lobar degeneration (FTLD), 104 patients with Alzheimer's disease, and 161 control subjects. We have replicated previous findings of decreased levels of progranulin protein in FTLD because of mutations in GRN and show this is not observed in FTLD cases because of other causes. interleukin-6 levels were increased in FTLD overall, but these did not discriminate between clinical and genetic subtypes.

Ejemplares similares